MFN2 and Hyperglycemia: The overactivated UPR branches such as PERK and ATF6 in hyperglycemia-treated cardiomyocytes can be alleviated by reducing MFN2 expression (137), and downregulation of MFN2 could attenuate mitochondrial dysfunction and ER-stress induced cardiomyocytes apoptosis (138).